GENCOR INDUSTRIES, INC.

GENC

CIK 0000064472 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$24M
↓-25.0% -$8Mvs FY2024 (Q4)
Operating Income
$3M
↓-32.9% -$2Mvs FY2024 (Q4)
Net Income
$2M
↓-50.4% -$2Mvs FY2024 (Q4)
Gross Profit
$7M
↓-22.1% -$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
53/100
  • Profitability
    2ROIC 5.3% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 23.44 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    26Asset Turnover 0.54x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -25.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    91Op Margin 13.2% · trend +2.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project GENC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$8.74
Total enterprise IV
$19M
Diluted shares
0.00B
Terminal PV
$14M (72% of total)
Year-5 FCF
$2M
YearProjected FCFDiscounted PV
+1$1M$1M
+2$1M$1M
+3$1M$1M
+4$2M$1M
+5$2M$1M
Terminal$22M$14M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$3M
investment in PP&E
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$229M
everything owned
Total liabilities
$14M
everything owed
Stockholders' equity
$215M
shareholder claim
Net debt
$-37M
Net cash position ($37M)

Recent performance · 64 quarters

Revenue↓-25.0% -$8M
$24M
Net Income↓-9.8% -$375K
$3M
Free Cash Flow↓-30.0% -$4M
$10M
Operating Margin↓-1.6pts
13.2%

Drill down